How the life sciences sector can address the greatest health challenges and reduce inequalities
Health Life sciencesHealth is one of our most untapped opportunities for prosperity and happiness, as both individuals and society. Yet these opportunities are not shared equally. The life sciences sector has a unique opportunity to actively reduce health inequalities.
We outline two key challenges facing society where the life sciences sector can make significant contributions to reducing inequalities. The first challenge is more people living with multiple conditions, the second is aligning financial incentives around patient and population health.
Throughout our report, we look at the drivers of inequalities across the medicine life cycle, envisioning what success looks like and sharing practical actions that could help achieve this vision. We explore the areas of pre-medicine approval, market access, post-approval, and the role of life science companies as employers.
By transforming health systems from importers of illness to exporters of health, we can make sure that health is prioritised as an asset, ultimately providing opportunities to individuals, societies and economies.
What's inside the report?
- Drivers of health inequalities across the medicine life cycle
- What success looks like – creating a health system with equity at its core
- Feasible actions the life science sector can take to help contribute positive change
